Salidroside inhibited the proliferation of gastric cancer cells through up-regulating tumor suppressor miR-1343-3p and down-regulating MAP3K6/MMP24 signal molecules

References

• Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584–11. doi:10.1097/CM9.0000000000002108.
   PubMed Web of Science ®Google Scholar
• Tang C, Zhao CC, Yi H, Geng ZJ, Wu XY, Zhang Y, Liu Y, Fan G. Traditional tibetan medicine in cancer therapy by targeting apoptosis pathways. Front Pharmacol. 2020;11:976. doi:10.3389/fphar.2020.00976.
   PubMed Web of Science ®Google Scholar
• Rong L, Li Z, Leng X, Li H, Ma Y, Chen Y, Song F. Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway. Biomed Pharmacother. 2020;122:109726. doi:10.1016/j.biopha.2019.109726.
   PubMed Web of Science ®Google Scholar
• Ren M, Xu W, Xu T. Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway. Artif Cells, Nanomed Biotechnol. 2019;47(1):1014–21. doi:10.1080/21691401.2019.1584566.
   PubMed Web of Science ®Google Scholar
• Jiang B, Feng LF, Yang T, Guo WJ, Li YY, Wang T, Liu C, Su H. Combination of chloroquine diphosphate and salidroside induces human liver cell apoptosis via regulation of mitochondrial dysfunction and autophagy. Mol Med Rep. 2023;27(2):37–47. doi:10.3892/mmr.2022.12924.
   PubMed Web of Science ®Google Scholar
• Shi X, Zhao W, Yang Y, Wu S, Lv B. Salidroside could enhance the cytotoxic effect of LOHP on colorectal cancer cells. Mol Med Rep. 2018;17:51–58. doi:10.3892/mmr.2017.7846.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Nie X, Li L, Liu HF, Peng YY, Zhou WT, Hu X-J, Xu X-Y, Chen X-L. Salidroside promotes sensitization to doxorubicin in Human cancer Cells by affecting the PI3K/Akt/HIF Signal Pathway and inhibiting the expression of tumor-resistance-related proteins. J Nat Prod. 2022;85(1):196–204. doi:10.1021/acs.jnatprod.1c00950.
   PubMed Web of Science ®Google Scholar
• Dai Z, Zhang X, Li W, Tang J, Pan T, Ma C, Guan Q. Salidroside induces apoptosis in human gastric cancer cells via the downregulation of ENO1/PKM2/GLUT1 expression. Biol Pharm Bull. 2021;44:1724–31. doi:10.1248/bpb.b21-00443.
   PubMed Web of Science ®Google Scholar
• Ma W, Wang Z, Zhao Y, Wang Q, Zhang Y, Lei P, Lu W, Yan S, Zhou J, Li X, et al. Salidroside suppresses the proliferation and migration of human lung cancer cells through AMPK-Dependent NLRP3 inflammasome regulation. Oxid Med Cell Longev. 2021;2021:1–12. doi:10.1155/2021/6614574.
   Web of Science ®Google Scholar
• Hao Y, Li Z, Chang M, Zhang X. Effects of salidroside combined with paclitaxel on proliferation, migration, and epithelial mesenchyme of colorectal cancer cells. Drug Des Devel Ther. 2022;16:4079–89. doi:10.2147/DDDT.S384151.
   PubMed Web of Science ®Google Scholar
• Li Y, Li S, Hu Q, Huang P. Salidroside inhibits proliferation, migration and invasion of human pancreatic cancer PANC1 and SW1990 cells through the AKT and ERK signaling pathway. Pharmazie. 2020;75(8):385–388. doi:10.1691/ph.2020.0556.
   PubMed Web of Science ®Google Scholar
• Zhu X, Liu D, Wang Y, Dong M. Salidroside suppresses nonsmall cell lung cancer cells proliferation and migration via microRNA-103-3p/Mzb1. Anticancer Drugs. 2020;31(7):663–671. doi:10.1097/CAD.0000000000000926.
   PubMed Web of Science ®Google Scholar
• Tsagakis I, Douka K, Birds I, Aspden JL. Long non-coding RNAs in development and disease: conservation to mechanisms. J Pathol. 2020;250(5):480–95. doi:10.1002/path.5405.
   PubMed Web of Science ®Google Scholar
• Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song SJ. Regulatory mechanism of microRNA expression in cancer. Int J Mol Sci. 2020;21(5):1723. doi:10.3390/ijms21051723.
   PubMed Web of Science ®Google Scholar
• Sharma N, Baruah MM. The microRNA signatures: aberrantly expressed miRnas in prostate cancer. Clin Transl Oncol. 2019;21(2):126–44. doi:10.1007/s12094-018-1910-8.
   PubMed Web of Science ®Google Scholar
• Liu X, Ma R, Yi B, Riker AI, Xi Y. MicroRNAs are involved in the development and progression of gastric cancer. Acta Pharmacol Sin. 2021;42(7):1018–26. doi:10.1038/s41401-020-00540-0.
   PubMed Web of Science ®Google Scholar
• So JBY, Kapoor R, Zhu F, Koh C, Zhou L, Zou R, Tang YC, Goo PCK, Rha SY, Chung HC, et al. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population. Gut. 2021;70(5):829–837. doi:10.1136/gutjnl-2020-322065.
   PubMed Web of Science ®Google Scholar
• Li CY, Liang GY, Yao WZ, Sui J, Shen X, Zhang YQ, Peng H, Hong W-W, Ye Y-C, Zhang Z-Y, et al. Identification and functional characterization of microRnas reveal a potential role in gastric cancer progression. Clin Transl Oncol. 2017;19(2):162–72. doi:10.1007/s12094-016-1516-y.
   PubMed Web of Science ®Google Scholar
• Weidle UH, Birzele F, Nopora A. microRnas promoting growth of gastric cancer xenografts and correlation to clinical prognosis. Cancer Genomics Proteomics. 2021;18(1):1–15. doi:10.21873/cgp.20237.
   PubMed Web of Science ®Google Scholar
• Chen L, Tang H, Liu G, Xiao S, Liang D, Ma J, Yang Y, Luo H, Zhu Y, Xie F, et al. MicroRNA-196b promotes gastric cancer progression by targeting ECRG4. Anticancer Drugs. 2021;32(2):127–37. doi:10.1097/CAD.0000000000000998.
   PubMed Web of Science ®Google Scholar
• Xing S, Tian Z, Zheng W, Yang W, Du N, Gu Y, Yin J, Liu H, Jia X, Huang D, et al. Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1. Mol Cancer. 2021;20(1):9. doi:10.1186/s12943-020-01295-2.
   PubMed Web of Science ®Google Scholar
• Pei LJ, Sun PJ, Ma K, Guo YY, Wang LY, Liu FD. LncRNA-SNHG7 interferes with miR-34a to desensitize gastric cancer cells to cisplatin. Cancer Biomark. 2021;30(1):127–137. doi:10.3233/CBM-201621.
   PubMed Web of Science ®Google Scholar
• Chen X, Wang J, Xie F, Mou T, Zhong P, Hua H, Liu P, Yang Q. Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression. Aging. 2020;12(14):14452–14466. doi:10.18632/aging.103487.
   PubMedGoogle Scholar
• Sun AQ, Ju XL. Advances in research on anticancer properties of Salidroside. Chin J Integr Med. 2021;27(2):153–60. doi:10.1007/s11655-020-3190-8.
   PubMed Web of Science ®Google Scholar
• Li H, Huang D, Hang S. Salidroside inhibits the growth, migration and invasion of Wilms’ tumor cells through down-regulation of miR-891b. Life Sci. 2019;222:60–68. doi:10.1016/j.lfs.2019.02.052.
   PubMed Web of Science ®Google Scholar
• Yang L, Yu Y, Zhang Q, Li X, Zhang C, Mao T, Liu S, Tian Z. Anti-gastric cancer effect of salidroside through elevating miR-99a expression. Artif Cells, Nanomed Biotechnol. 2019;47(1):3500–3510. doi:10.1080/21691401.2019.1652626.
   PubMed Web of Science ®Google Scholar
• Wang XP, Wang QX, Lin HP, Xu B, Chang N, Chao X, Shi H, Meng B. Biotherapeutic mechanism of salidroside on gastric carcinoma cells. IOP Conf Ser: Mater Sci Eng. 2019;592(1):012016. doi:10.1088/1757-899X/592/1/012016.
   Google Scholar
• Zhou QY, Peng PL, Xu YH. MiR-221 affects proliferation and apoptosis of gastric cancer cells through targeting SOCS3. Eur Rev Med Pharmacol Sci. 2019;23(21):9427–35. doi:10.26355/eurrev_201911_19436.
   PubMed Web of Science ®Google Scholar
• Gao S, Gang J, Yu M, Xin G, Tan H. Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer. BMC Cancer. 2021;21(1):791. doi:10.1186/s12885-021-08520-1.
   PubMed Web of Science ®Google Scholar
• Hu S, Zheng Q, Wu H, Wang C, Liu T, Zhou W. miR-532 promoted gastric cancer migration and invasion by targeting NKD1. Life Sci. 2017;177:15–9. doi:10.1016/j.lfs.2017.03.019.
   PubMed Web of Science ®Google Scholar
• Zhang L, Guo X, Zhang D, Fan Y, Qin L, Dong S, Zhang L. Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway. Mol Carcinog. 2017;56(9):2022–2034. doi:10.1002/mc.22656.
   PubMed Web of Science ®Google Scholar
• Kim H, Yang JM, Jin Y, Jheon S, Kim K, Lee CT, Chung J-H, Paik JH. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status. Oncotarget. 2017;8(5):8484–8498. doi:10.18632/oncotarget.14298.
   PubMedGoogle Scholar
• Okimoto RA, Bivona TG. Metastasis: From head to tail. Cell Cycle. 2017;16(6):487–488. doi:10.1080/15384101.2016.1271636.
   PubMed Web of Science ®Google Scholar
• Eto N, Miyagishi M, Inagi R, Fujita T, Nangaku M. Mitogen-activated protein 3 kinase 6 mediates angiogenic and tumorigenic effects via vascular endothelial growth factor expression. Am J Pathol. 2009;174(4):1553–63. doi:10.2353/ajpath.2009.080190.
   PubMed Web of Science ®Google Scholar
• Gao S, Tan H, Li D. Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis. J Cell Mol Med. 2023;27(18):2661–74. doi:10.1111/jcmm.17841.
   PubMedGoogle Scholar
• Hambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metasis. J Natl Cancer Inst. 1997;89(17):1260. doi:10.1093/jnci/89.17.1260.
   PubMedGoogle Scholar
• Sounni NE, Noel A. Membrane type-matrix metalloproteinases and tumor progression. Biochimie. 2005;87(3–4):329–42. doi:10.1016/j.biochi.2004.07.012.
   PubMed Web of Science ®Google Scholar
• English WR, Holtz B, Vogt G, Knäuper V, Murphy G. Characterization of the role of the “MT-loop”. J Biol Chem. 2001;276(45):42018–42026. doi:10.1074/jbc.M107783200.
   PubMed Web of Science ®Google Scholar
• Puente XS, Pendás AM, Llano E, Velasco G, López-Otín C. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 1996;56(5):944–949.
   PubMed Web of Science ®Google Scholar
• Llano E, Pendás AM, Freije JP, Nakano A, Knäuper V, Murphy G, López-Otin C. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors. Cancer Res. 1999;59(11):2570–2576.
   PubMed Web of Science ®Google Scholar
• de la Peña S, Sampieri CL, Ochoa-Lara M, León-Córdoba K, Remes-Troche JM, de la Peña S. Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer. Dis Markers. 2014;2014:1–9. doi:10.1155/2014/285906.
   Web of Science ®Google Scholar
• Li H, Liu J, Lai Y, Huang S, Zheng L, Fan N. LINC01559 promotes colorectal cancer via sponging miR-1343-3p to modulate PARP1/PTEN/AKT pathway. Pathol Res Pract. 2021;224:153521. doi:10.1016/j.prp.2021.153521.
   PubMed Web of Science ®Google Scholar
• Zhang X, Du L, Han J, Li X, Wang H, Zheng G, Wang Y, Yang Y, Hu Y, Wang C, et al. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma. Thorac Cancer. 2020;11(9):2506–16. doi:10.1111/1759-7714.13562.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao Z, Sun D, Li Y. Novel long noncoding RNA LINC02323 promotes cell growth and migration of ovarian cancer via TGF-β receptor 1 by miR-1343-3p. J Clin Lab Anal. 2021;35(2):e23651. doi:10.1002/jcla.23651.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Huang T, Zhang J, Wong CC, Zhang B, Dong Y, Wu F, Tong JHM, Wu WKK, Cheng ASL, et al. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Oncogene. 2017;36(47):6518–30. doi:10.1038/onc.2017.257.
   PubMed Web of Science ®Google Scholar